Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
ROIC: Strong Returns
Trending higher, above historical average, structural decline.
Left:
||||
Return on invested capital
Latest
-21.39%
↑ 37% above average
Average (9y)
-33.76%
Historical baseline
Range
High:-19.89%
Low:-74.17%
CAGR
-12.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -21.39% | +21.3% |
| 2023 | -27.18% | -27.5% |
| 2022 | -21.32% | +44.4% |
| 2021 | -38.37% | -56.0% |
| 2020 | -24.59% | -23.7% |
| 2019 | -19.89% | +54.4% |
| 2018 | -43.60% | -86.9% |
| 2017 | -23.33% | +46.6% |
| 2016 | -43.73% | +41.0% |
| 2015 | -74.17% | - |